Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that cosmetics need biocompatible, eco-friendly ingredients due to aging populations and demand for effective products.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Surfactants damage hair, but sealing the cuticle can prevent this.

RF-based therapies might help treat hair loss.

A group has developed therapies that show promise for treating cancer and various other conditions.

Red pigmented rice, like Sang-Yod rice, could help promote hair growth and prevent hair loss.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Luteolin can reduce hair graying in mice, with external treatment being more effective.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

FUE is a versatile hair transplant technique with many uses and good outcomes when performed with skill.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Severe and early hair loss may indicate a higher risk of heart disease.

Alopecia areata in elderly people is usually mild and responds well to treatment.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.